--2025/Q1-- / 50.000K--
--2024/Q4-- / 6.080M--
Nov 6, 20242024/Q30.000 / 80.000K--
Aug 6, 20242024/Q20.000 / 88.890K--
May 2, 20242024/Q110.007M / 109.090K--
Oracle
ORCL
NVIDIA
NVDA
Microsoft
MSFT
D.R. Horton
DHI
Lennar Corp
LEN
US Stock MarketDetailed Quotes
RLAY Relay Therapeutics
- 4.920
- +0.260+5.58%
Close Jan 22 16:00 ET
- 4.940
- +0.020+0.41%
Post 20:01 ET
823.52MMarket Cap-1.89P/E (TTM)
5.050High4.630Low2.38MVolume4.650Open4.660Pre Close11.65MTurnover1.87%Turnover RatioLossP/E (Static)167.38MShares11.16052wk High0.98P/B627.05MFloat Cap3.50052wk Low--Dividend TTM127.45MShs Float64.370Historical High--Div YieldTTM9.01%Amplitude3.500Historical Low4.885Avg Price1Lot Size
Relay Therapeutics Key Stats
Relay Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Relay Therapeutics Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data